Thymulin 50mg — Vial Spec, Reconstitution Math & COA

Overview of the 50mg Thymulin Vial Specification and Availability

Thymulin is a naturally occurring thymic nonapeptide hormone that plays a pivotal role in modulating cellular signaling pathways, T-cell differentiation, and zinc-dependent immunological functions. In high-throughput preclinical research, utilizing larger mass specifications such as a 50mg vial enables laboratories to conduct continuous, long-term exposure assays on primary cell cultures, T-lymphocyte lineages, and isolated thymocyte populations.

Please note that while PX1 Research manufactures and stocks standard laboratory fill sizes like Thymulin 10mg for standard protocol evaluation, the 50mg mass specification is typically produced for custom institutional orders and bulk synthesis requests. Principal investigators requiring 50mg fills or larger custom runs can coordinate directly with our team through PX1 Wholesale Accounts. For smaller screening protocols or initial pilot studies, researchers can browse our complete catalog of all research peptides to select ready-to-ship unit quantities.

Biochemical Identity and Molecular Structure of Thymulin

Thymulin (formerly known as Facteur Thymique Sérique or FTS) is a biologically active nonapeptide with the primary amino acid sequence Pyr-Glu-Ala-Lys-Ser-Gln-Gly-Gly-Ser-Asn-OH. It exhibits an exact molecular weight of approximately 858.85 g/mol in its unchelated peptide form. A critical structural feature of Thymulin is its absolute requirement for equimolar zinc (Zn2+) coordination to achieve its bioactive conformation.

In physiological and laboratory settings, unchelated Thymulin remains biologically inactive until bound to zinc ions. Preclinical studies suggest that the Zn-Thymulin complex induces specific biological activity by binding to high-affinity plasma membrane receptors on target cells, activating downstream intracellular kinase cascades. When evaluating thymic signaling mechanisms, researchers frequently compare Thymulin with other thymic factors such as Thymosin Alpha-1 and Thymosin Beta-4 to map distinct pathways of T-cell maturation and immune cell recruitment.

Reconstitution Math for a 50mg Mass Specification

Accurate reconstitution is vital when handling a 50mg lyophilized mass to ensure precise molar concentrations during microplate dosing and cell culture supplementation. Because a 50mg mass is substantially larger than standard analytical fills, selection of diluent volume (typically Bacteriostatic Water, Sterile Water for Injection, or Phosphate-Buffered Saline) directly dictates final stock concentration.

Below are the calculated concentrations resulting from adding standard liquid diluent volumes to a single 50mg vial of Thymulin:

• Reconstitution with 1.0 mL Diluent: Yields a final concentration of 50.0 mg/mL (50,000 µg/mL). At this concentration, every 10 µL of solution delivers 500 µg (0.5 mg) of active nonapeptide mass.

• Reconstitution with 2.0 mL Diluent: Yields a final concentration of 25.0 mg/mL (25,000 µg/mL). At this concentration, every 10 µL of solution delivers 250 µg (0.25 mg) of active nonapeptide mass.

• Reconstitution with 3.0 mL Diluent: Yields a final concentration of 16.67 mg/mL (16,667 µg/mL). At this concentration, every 10 µL of solution delivers approximately 166.7 µg of active nonapeptide mass.

For custom diluent volumes or complex molar calculations requiring molarity adjustments based on lot-specific peptide purity percentages, researchers should utilize the interactive reconstitution calculator to eliminate manual calculation errors prior to laboratory liquid handling.

Aliquot Planning and Liquid Handling Strategy

Once a 50mg vial is reconstituted, repeated freeze-thaw cycles must be rigorously avoided. Freeze-thaw stress leads to peptide backbone cleavage, aggregation, and loss of receptor-binding affinity in aqueous media. A structured aliquot strategy ensures long-term reagent stability across multi-week research schedules.

Immediately following full dissolution in sterile media or buffer, the stock solution should be transferred into low-binding polypropylene cryovials in single-use aliquot volumes (e.g., 50 µL to 100 µL per tube). These aliquots should be snap-frozen in liquid nitrogen or a dry ice/ethanol bath and stored at -20°C or -80°C. Individual aliquots can then be thawed once, immediately prior to dosing culture wells, discarding any unused working liquid at the conclusion of the daily protocol.

Lot-Matched COA Standards & Purity Verification

Every batch of Thymulin synthesized for PX1 Research undergoes strict analytical verification prior to final vial filling and seal crimping. We enforce full transparency by issuing a lot-matched Certificate of Analysis (COA) for every batch produced. Researchers can verify their specific lot documentation online via our dedicated COA Lookup portal.

Quality assurance testing for Thymulin includes High-Performance Liquid Chromatography (HPLC) to confirm peptide purity exceeds 98.0%, combined with Mass Spectrometry (MS) to verify molecular weight accuracy and sequence integrity. Crucially, because Thymulin is regularly evaluated in delicate cellular assays and immune signaling pathways, every lot is subjected to Chromogenic LAL (Limulus Amebocyte Lysate) testing to verify endotoxin levels remain strictly under <0.01 EU/mg, preventing baseline cellular inflammation artifacts.

Preclinical Mechanisms: T-Cell Differentiation & Immune Signaling

In vitro data indicate that Thymulin exerts primary activity on immature T-lymphocyte populations, stimulating the expression of specific differentiation markers such as CD3, CD4, and CD8. The hormone acts through G-protein coupled plasma membrane receptors, inducing intracellular cyclic AMP (cAMP) generation and activating downstream signal transduction networks.

Preclinical studies suggest that the biological activity of Thymulin extends to modulating neuroendocrine-immune interactions. In animal models, thymic factor activity has been observed to influence hypothalamic-pituitary-adrenal (HPA) axis balance and peripheral cytokine secretion profiles (including IL-2, IFN-gamma, and TNF-alpha). Researchers interested in broader immunomodulatory cascades can explore comparative data within our Research Library Hub.

Vial Selection Guide: 10mg vs. 50mg Formats

Selecting between a standard 10mg vial and a bulk 50mg vial depends primarily on experimental scale, total liquid handling volume, and study duration. For short-term exploratory screening, single-plate assays, or method validation, purchasing standard unit fills like Thymulin 10mg minimizes open liquid volume and reduces storage overhead.

Conversely, high-throughput screening facilities, robotics-assisted automated liquid handlers, and multi-animal rodent cohorts benefit significantly from 50mg mass fills. Processing a single large vial standardizes the baseline reagent pool across hundreds of experimental wells, eliminating micro-variations that can occur when mixing multiple smaller lots. Evaluating overall workflow requirements across our catalog of research peptides helps laboratory procurement staff optimize expenditure while maintaining assay reproducibility.

Laboratory Storage, Handling, and Stability Protocols

To preserve structural stability and prevent chemical degradation, unchelated and zinc-chelated lyophilized Thymulin powder must be stored in temperature-controlled freezers upon delivery. Unopened vials remain stable at -20°C for up to 24 months, or at -80°C for extended archival storage.

Key environmental protocols for handling Thymulin include:

• Temperature Controls: Avoid exposure to ambient room temperatures (>22°C) for extended periods during weighing or reconstitution.

• Light Sensitivity: Lyophilized cake and reconstituted solutions should be protected from direct UV light exposure.

• Atmosphere Integrity: Vials are sealed under inert nitrogen atmosphere to prevent oxidative modification of amino acid residues (particularly Methionine or Glutamine side chains).

Comparative Analysis: Thymic Factors and Immunomodulatory Peptides

When designing comparative immune signaling panels, investigators frequently evaluate Thymulin alongside other well-characterized regulatory peptides. Each compound interacts with distinct cell-surface receptors and signaling pathways:

• Thymulin vs. Thymosin Alpha-1: While Thymulin operates as a zinc-dependent nonapeptide targeting early T-cell maturation and neuroendocrine pathways, Thymosin Alpha-1 is a 28-amino-acid peptide heavily involved in Toll-like receptor (TLR) signaling and dendritic cell activation.

• Thymulin vs. Antimicrobial Peptides: Compounds like LL-37 act directly via membrane disruption and chemotactic recruitment, whereas Thymulin operates primarily through receptor-mediated enzymatic cascades.

• Thymulin vs. Tissue Repair Signalers: Cytoprotective agents such as BPC-157 target angiogenic pathways and nitric oxide signaling, contrasting sharply with the lymphocyte-specific differentiation effects of thymic nonapeptides.

PX1 Research Quality & Supply Chain Commitment

PX1 Research operates strictly as a USA-based supplier of high-purity research compounds engineered exclusively for laboratory and in vitro evaluation. All peptide manufacturing occurs within GMP-compliant facilities utilizing state-of-the-art solid-phase peptide synthesis (SPPS) equipment.

Every batch is verified through an independent ISO 17025 accredited testing facility to guarantee identity, exact mass concentration, and purity parameters. Orders placed Monday through Friday ship same-day from our primary fulfillment nodes in California and Arizona, ensuring minimal transit times and thermal integrity for temperature-sensitive reagents.